MGMT and SPOCK2 promoter methylation in diffuse large B-Cell lymphoma: a study in two tertiary health centres in the East Coast of Malaysia = Metilasi promoter MGMT dan SPOCK2 dalam diffuse large B-cell lymphoma: satu kajian yang dijalankan di dua pusat Kesihatan di Pantai Timur Malaysia

QR Code

MGMT and SPOCK2 promoter methylation in diffuse large B-Cell lymphoma: a study in two tertiary health centres in the East Coast of Malaysia = Metilasi promoter MGMT dan SPOCK2 dalam diffuse large B-cell lymphoma: satu kajian yang dijalankan di dua pusat Kesihatan di Pantai Timur Malaysia

MGMT (O6-Methylguanine-DNA Methyltransferase) suppresses tumor development by removing alkyl adduct, while SPOCK2 (SPARC/Osteonectin CWCV and Kazal-like domains proteoglycan) abolishes the inhibition of membrane-type matrix metalloproteinases (MT-MMP) which leads to angiogenesis. Hence, MGMT methyla...

Full description

Bibliographic Details
Main Authors:	Zainuddin, Norafiza, Mohd. Ridah, Lailatul Jalilah, Omar, Aqilah Nabihah, A. Talib, Norlelawati, Muhammad, Siti Aeshah @ Naznin, Hussain, Faezahtul Arbaeyah
Format:	Article
Language:	English
Published:	Universiti Kebangsaan Malaysia 2017
Subjects:	RB Pathology RC254 Neoplasms. Tumors. Oncology (including Cancer)
Online Access:	http://irep.iium.edu.my/56529/ http://irep.iium.edu.my/56529/1/56529_MGMT%20and%20SPOCK2%20Promoter%20Methylation.pdf

Similar Items

Methylation status of MGMT and SPOCK2 in diffuse large B-cell lymphoma
by: Zainuddin, Norafiza, et al.
Published: (2016)

Epigenetic methylation status of P16, MGMT and SPOCK2 in diffuse Large B cell lymphoma
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2016)

Methylation-specific PCR Revealed Aberrant Promoter Gene Methylation of p16, MGMT and SPOCK2 in Diffuse Large B-cell Lymphoma
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2015)

MGMT and SPOCK2 promoter methylation in diffuse large B-Cell lymphoma: a study in two tertiary health centres in the East Coast of Malaysia
by: Norafiza Zainuddin,, et al.
Published: (2017)

Epigenetic silencing status of p16INK4a and MGMT promoter regions identified qualitatively in diffuse large B cell lymphoma
by: Mohd Ridah, L Jalilah, et al.
Published: (2015)

Detection of p16INK4a (p16) methylation in diffuse large B-cell lymphoma using methylation-specific PCR
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2014)

p16 tumor suppressor gene methylation in diffuse large B cell lymphoma: a study of 88 cases at two hospitals in the east coast of Malaysia
by: Mohd Ridah, Lailatul Jalilah, et al.
Published: (2017)

Pyrosequencing-based quantitative identification of p16 methylation in diffuse large B-cell lymphoma at two centres in the East Coast of Malaysia
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2016)

Diffuse large B-cell lymphoma presenting with extensive cutaneous infiltration.
by: Shamsudin, Norashikin, et al.
Published: (2012)

Immunohistochemical expression of hedgehog proteins in diffuse large B-cell lymphoma
by: Azman, Siti Nur Lina
Published: (2016)

The immunohistochemical studies of double or triple protein lymphoma in diffuse large B-cell lymphoma and their correlation with clinicopathological parameters
by: Wahab, Wan Nor Najmiyah Wan Abdul
Published: (2017)

Qualitative detection of p16INK4a tumor suppressor gene methylation in diffuse large b-cell lymphoma using methylation-specific PCR
by: Mohd. Ridah, Lailatul Jalilah, et al.
Published: (2014)

Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases
by: Boyle, Terry, et al.
Published: (2017)

Quantitative evaluation of p16INK4a promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
by: Zainuddin, Norafiza, et al.
Published: (2011)

The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma
by: Hedstrom, Gustav, et al.
Published: (2014)

Diffuse large B-cell lymphoma of the small intestine in a patient with refractory coeliac disease.
by: Ahmad Affandi, Khairunisa, et al.
Published: (2019)

Expression profile of HIP1R in B-cell subsets and in silico prediction of its functions in diffuse large B-cell lymphoma
by: Keng, Wong Kah
Published: (2018)

TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype
by: Zainuddin, Norafiza, et al.
Published: (2008)

Patched-1 and smoothened, a hedgehog receptor and signal transducer are highly expressed in diffuse large B-cell lymphoma
by: Azman, Siti Nur Lina, et al.
Published: (2017)

Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomas
by: Hirpara, J., et al.
Published: (2016)

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
by: Morin, R., et al.
Published: (2010)

The Role Of 18F -FDG PET-CT In Assessing Bone Marrow Involvement In Diffuse Large B-Cell Lymphoma (DLBCL)
by: Nasir, Siti Maisarah Mohd
Published: (2018)

Identification of MYC/BCL2 double-expressers lymphomas in diffuse large B cell lymphoma patients and association with their prognostic parameters and survival rates: a single centre experience
by: Ahmad, Aliza, et al.
Published: (2022)

Primary cutaneous anaplastic large cell lymphoma with lung metastasis
by: Esa, Nor Kamaruzaman, et al.
Published: (2016)

Primary cutaneous anaplastic large cell lymphoma with lung metastasis

Clinical Outcomes Of Induction TherapyWith Addition Of High Dose Methotrexate And Cytarabine To Existing Standard Treatment In Patients With Newly Diagnosed Diffused Large B-Cell Lymphoma: A Retrospective Study
by: Dang, Chee Chean
Published: (2018)

The period prevalence of double expression diffuse large B-cell lymphoma patients and its associated risk factors and treatment response in Hospital Universiti Sains Malaysia from 2004 to 2015
by: Yong, Teh Chee
Published: (2017)

Group- based quantitative structural activity relationship analysis of B-cell Lymphoma Extra Large (BCL-XL) inhibitors
by: Abdul Samat, Nadia Hanis, et al.
Published: (2014)

Involvement of the P53 pathway and P161NK4A in the pathogenesis of b-cell lymphomas
by: Zainuddin, Norafiza
Published: (2011)

Small cell variant of anaplastic large cell lymphoma with positive immunoreactivity for CD99
by: Mohd Sidik, Shiran, et al.
Published: (2008)

Temozolomide analog PMX 465 downregulates MGMT expression in HCT116 colorectal carcinoma cells
by: Yang, Zhikuan, et al.
Published: (2018)

Molecular genetic analysis in B-cell Lymphomas : a focus on the p53 pathway and p16INK4a
by: Zainuddin, Norafiza
Published: (2010)

Anaplastic large cell lymphoma presenting as a soft tissue mass – A case report
by: Siti-Aishah M.A.,, et al.
Published: (2008)

The expression of IL-21 is promoted by MEKK4 in malignant T cells and associated with increased progression risk in cutaneous T-cell lymphoma
by: Fredholm, Simon, et al.
Published: (2016)

Mantle Cell Lymphoma Masquerading as obstructive sleep apnoea
by: Ishak, Noor Liza, et al.
Published: (2022)

Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines
by: Ikeda, Jun-ichiro, et al.
Published: (2010)

The novel role of the B-cell lymphoma/leukemia 11A (BCL11A) gene in β-thalassaemia treatment
by: Lai, Mei I, et al.
Published: (2023)

Malignant inflammation in cutaneous T-cell lymphoma: a hostile takeover
by: Krejsgaard, Thorbjørn, et al.
Published: (2016)

The evaluation of 06-methylguanine-DNA-methyltransferase (MGMT) gene methylation status among Hospital Universiti Sains Malaysia glioma patients
by: Murali, Revathy
Published: (2018)

Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells
by: Ikeda, Jun-ichiro, et al.
Published: (2012)